Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Eisai to present full findings from lecanemab confirmatory phase 3 clinical trial (clarity ad) and other alzheimer's disease research at the 15th clinical trials on alzheimer's disease (ctad) conferen

TOKYO , Nov. 20, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the effi...

November 20, 2022, 6:30 pm

Novavax ceo says covid-19 shot could be cleared for the u.s. by may

Novavax is currently conducting three efficacy trials for its Covid-19 vaccines. The vaccine is 96 perc...

November 19, 2022, 8:59 am

How j&j's covid vaccine efficacy compares to the other candidates

Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, tweeted his reaction to Johnson & Johnson...

November 19, 2022, 8:13 am

European equity close: strong day to mark another week of gains

Closing changes for the main European markets:

• Stoxx 600+1.1%
• UK FTSE 100 +0.5%
• German DAX +1.2%
• French ...

  November 18, 2022, 4:39 pm

Hap president and ceo andy carter to retire

Harrisburg, PA, Nov. 18, 2022 (GLOBE NEWSWIRE) — Andy Carter, president and CEO of The Hospital and Healthsystem Association of Pennsylvania (HAP) s...

November 18, 2022, 3:05 pm

Us opening bell 18-11-2022

EUROPEAN EQUITIES REMAIN POSITIVE AT MID-SESSION; UK RETAIL SALES TOP ESTIMATES, WHILE THE CHINESE COVID SITUATION WEIGHS ON OIL. The major European i...

November 18, 2022, 12:58 pm

Equities push a little higher on the session

• S&P 500 futures +0.4%
• Nasdaq futures +0.5%
• Dow futures +0.4%
• Eurostoxx +1.1%
• Germany DAX +1.1%
• France ...

  November 18, 2022, 9:38 am

German dax closes higher. other european indices close lower

The German Dax is the only major European indice which is closing higher on the day. Looking at the closing levels:

• German Dax, +0.23%...

  November 17, 2022, 4:56 pm

Us opening bell 17-11-2022

EUROPEAN EQUITIES EDGE LOWER AHEAD OF THE US OPENING SESSION; EU CPI CAME IN LINE WITH EXPECTATIONS, WHILE US RETAIL SALES DATA SHOWED RESILIENCE; EYE...

November 17, 2022, 2:37 pm

Editas medicine announces clinical data demonstrating proof of concept of edit-101 from phase 1/2 brilliance trial

EDIT-101 demonstrates a favorable safety profile across all dose cohorts Preliminary efficacy signals o...

November 17, 2022, 12:15 pm

European equities open higher to start the day

• Eurostoxx +0.5%
• Germany DAX +0.8%
• France cac 40 +0.4%
• UK FTSE -0.1%...

  November 17, 2022, 8:06 am

Us opening bell 16-11-2022

EUROPEAN STOCKS EDGE LOWER AMID GROWING GEOPOLITICAL TENSIONS; UK’S CPI PRINTED ANOTHER RECORD HIGH, WHILE INVESTORS AWAIT FOR US RETAIL SALES DATA....

November 16, 2022, 1:39 pm

Essa pharma: epi-7386+xtandi combination has shown highest efficacy in metastatic, castration-resistant prostate cancer

The stock has pulled back from the 2x pop after the recent data of EPI-7386+Xtandi in post-chemotherapy metastatic castration-resistant prostate cance...

November 15, 2022, 10:01 pm

Us opening bell 15-11-2022

EUROPEAN EQUITIES MIXED AHEAD OF THE US OPENING BELL; UK DATA KEEP PRESSURE ON THE BOE TO HIKE INTEREST RATES; EU DATA HELP SENTIMENT, BUT INVESTORS S...

November 15, 2022, 1:00 pm

European stocks open higher to start the day

• Eurostoxx +0.4%
• Germany DAX +0.3%
• France cac 40 +0.3%
• UK FTSE flat
...

November 15, 2022, 8:09 am